Kinos Medical Merges with Restor3d

Kinos Medical Merges with Restor3d

by Medical

restor3d merger with Kinos Medical, an expert total ankle replacement company. restor3d was founded with a mission to enable surgeons to repair and reconstruct the human body using 3D printing technologies, advanced biomaterials, and artificial intelligence. In 2018, the company invested in significant infrastructure and in-house manufacturing capabilities to expand its offering of implants in orthopedic and spine indications. With a robust pipeline of products slated for regulatory submission, recent FDA clearances include osteotomy wedges and cervical interbody fusion implants. The merger with Kinos Medical will accelerate restor3d’s expansion into the high-growth foot and ankle market in the U.S.

Desktop Health Receives CE Certification for Flexcera AM dentures Medical

Desktop Health Receives CE Certification for Flexcera AM Dentures

by Medical

Desktop Health, a service recently launched by Desktop Metal, received the Conformité Européenne (CE) Mark certification for its Flexcera resin, a proprietary technology for use in 3D fabrication of high-quality dental prosthetics. The CE Mark affirms that Flexcera resins meet the requirements of the European Medical Devices Directive, paving the way for Desktop Health to launch Flexcera resins to dental professionals within the European Union (EU) and other CE Mark geographies. Flexcera Base, which recently received U.S. Food and Drug Administration (FDA), and Flexcera Smile are Desktop Health’s first formulated and optimized digital dental solutions.

FluidForm to Develop New 3D Bioprinting Solutions for J&J Bioprinting

FluidForm to Develop New 3D Bioprinting Solutions for J&J Bioprinting

by Medical

FluidForm, an expert in the field of human tissue for research, repair, and replacement signed an agreement with Ethicon, a member of the Johnson & Johnson Medical Devices Companies, to develop 3D bioprinted applications using FluidForm’s patented FRESH technology. This collaboration leverages FluidForm’s FRESH 3D bioprinting platform to achieve specific tissue characteristics that cannot be manufactured with conventional techniques.